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Introduction
Opioid compounds such as morphine and heroin are highly addictive and are among commonly abused drugs due to their strong rewarding effect, ultimately leading to opioid dependence and addiction, a psychoneurological disease and disturbing social problem for which effective treatments are still lacking (Nestler, 2004; Woolf and Hashmi, 2004; Koob and Le Moal, 2008) . Several brain regions, including the ventral tegmental area and the nucleus accumbens, have been classically implicated in the mechanisms of reward and addiction to many abused drugs including opioids. In these brain regions, important adaptive changes have been identified that are thought to contribute to the compulsive behavior of opioid abuse induced by repeated exposure to opioid drugs (Williams et al., 2001; Koob and Le Moal, 2008) . Recently, the amygdala complex including the central nucleus of the amygdala (CeA), a forebrain structure well known for mediating negative emotional responses such as fear (McKernan and Shinnick-Gallagher, 1997; Rogan et al., 1997; Garcia et al., 1999) , has been increasingly recognized as a critical player also in positive emotional responses characterized in the process of positive stimulus-reward learning and in drug-seeking behaviors (Baxter and Murray, 2002; Gottfried et al., 2003; See et al., 2003) . Among many targets of long-term opioids, central glutamate synaptic transmission has been identified as a key component that undergoes significant molecular, pharmacological and physiological adaptations after prolonged opioid exposure (Carlezon and Nestler, 2002; Siggins et al., 2003; Jones and Bonci, 2005) .
Opioid actions are mediated primarily by three types of classic opioid receptors: mu-opioid receptor (MOR), delta-opioid receptor (DOR) and kappa-opioid receptor (Pan, 1998; Williams et al., 2001; Waldhoer et al., 2004) . Previous studies have clearly This article has not been copyedited and formatted. The final version may differ from this version. (Matthes et al., 1996; Contet et al., 2004) . However, little is known at present about the function of DOR, which is also abundantly expressed in those reward-related brain areas including the CeA, in opioid reward and in adaptive changes of the endogenous opioid system leading to compulsive opioid-seeking behaviors and opioid abuse (Kieffer and Gaveriaux-Ruff, 2002) . Because direct antagonism of MOR in an opioid-dependent state inevitably causes devastating syndromes of opioid withdrawal (Williams et al., 2001 ), understanding of the adaptive function of DOR and those of other affected signaling systems may provide more appropriate targets to circumvent the problems of opioid dependence and addiction. Therefore, in this study, we investigated the action of DOR and its adaptive changes in CeA neurons from rats that display morphine-induced behavior of conditioned-place preference (CPP), a behavioral measure well established for the rewarding effect of many drugs of abuse in animals (Tzschentke, 2007) .
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CPP.
A standard rat CPP apparatus (Med Associates Inc., St. Albans, VT) was used for analysis of morphine-induced reward behavior in rats, as we reported previously (Zhu et al., 2007) . The CPP apparatus had two test chambers with distinct environmental cues: a black chamber with stainless steel rod grid floor and a white chamber with stainless steel mesh floor. A third center compartment in neutral gray connected the two test chambers with operational doors. Automated data were collected by fifteen infrared photobeam detectors on chamber floors and were automatically sent to a computer for storage and analysis. The conditioning procedure consisted of four phases and lasted for a total of 12 consecutive days. Phase 1, habituation (days 1-2): after a saline injection (i.p.), a rat was placed in the center compartment and allowed to move freely between the two test chambers for 30 minutes each day. Phase 2, pre-test (day 3): after a saline injection (i.p.), the rat was placed in the center compartment and a preference test was conducted by recording the time the rat spent in each of the two test chambers during a 30-min test period. This pre-test determined baseline preference and equipment bias. Phase 3, morphine conditioning (days 4-11): rats were randomly assigned to saline and morphine groups; on day 4, the rat in the morphine group was injected with morphine (10 mg/kg, i.p.) and was immediately confined in a chamber for 20 minutes. Morphine conditioning was paired with the non-preferred chamber in this study with equipment bias to prevent This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on January 23, 2009 as DOI: 10.1124 at ASPET Journals on May 2, 2016 jpet.aspetjournals.org Downloaded from JPET #148908 7 potential influence of a ceiling effect in CPP tests. CPP was also consistently induced by drugs paired with the preferred chamber for alcohol (Zhu et al., 2007) and morphine (data not shown). On day 5, the rat was injected with saline and confined in the other chamber for 20 min. The same procedure of morphine and saline conditioning on alternate days was repeated on days 6 & 7 through days 10 & 11. In the saline control group, rats received saline injection on all 8 conditioning days. Phase 4, post-test (day 12): after a saline injection (i.p.), the conditioned rat was placed in the center compartment and allowed to move freely between the two test chambers for 30 minutes, and the time the rat spent in each test chamber was automatically recorded to determine CPP behavior. On day 13, an i.p. injection of saline or naloxone (1.5 mg/kg) was made on a conditioned rat, followed by a CPP test to determine the drug effect on the existing CPP behavior.
Brain slice preparations.
A rat was anesthetized with inhalation of halothane and then euthanized by decapitation. The brain was removed and cut in a vibratome in cold (4 °C) physiological saline to obtain coronal slices (200-300 μm thick) containing the CeA. A single slice was submerged in a shallow recording chamber and perfused with preheated (35 °C) physiological saline (in mM: NaCl, 126; KCl, 2.5; NaH 2 PO 4 , 1.2; MgCl 2 , 1.2; CaCl 2 , 2.4; glucose, 11; NaHCO 3 , 25, saturated with 95% O 2 and 5% CO 2 , pH 7.2-7.4).
Slices were maintained at around 35 °C throughout a recording experiment. Junction potential was not corrected. Recordings were made in a morphine-free solution 1-4 hours after making the slice preparation from morphine-or saline-treated rats on the same day as behavioral tests.
Glutamate synaptic currents. Electrical stimuli of constant current (0.25 ms, 0.04-0.5 mA) were used to evoke glutamate-mediated excitatory postsynaptic current (EPSCs) with bipolar stimulating electrodes (FHC Inc., Bodowinham, ME) placed in the ventrolateral part of the CeA. All EPSCs were recorded in the presence of GABA A receptor antagonist bicuculline (30 μM). Under our experimental conditions, the EPSC is mediated predominantly by non-NMDA receptors and no glycine or GABA B receptor-mediated synaptic current is detectable in CeA neurons (Zhu and Pan, 2004) . The glutamate synaptic strength between control and morphine-treated groups was studied with three stimulus intensities: maximum intensity to elicit a maximum EPSC, 2/3 of the maximum intensity and 1/3 of the maximum. For paired-pulse ratios (PPR), a pair of EPSCs was evoked by two stimuli with an interval of 40, 60 and 80 ms and the PPR at each interval was calculated by dividing the second EPSC amplitude by the first one. Six PPRs were averaged to obtain a mean PPR before and during application of a drug in a given cell. The PPR, which has been widely used to determine the involvement of a presynaptic action site Synaptosome preparations. The protocol for preparing synaptosomes was generally based on previous reports (Sbrenna et al., 2000; Dunkley et al., 2008) . CeA tissues from saline-and morphine-treated rats were gently homogenized in ice-cold 0.32 M sucrose buffer at pH 7.4, and then centrifuged for 10 min at 1000×g (4°C). The supernatant was collected and centrifuged for 20 min at 10,000×g (4°C), then the synaptosomal pellet was resuspended in the lysis buffer (0.1% Triton X-100, 150 mM NaCl, 25 mM KCl, 10 mM tris.HCl, pH 7.4, with protease inhibitors) at 4°C for 10 min. For total protein preparations, as we previously described (Ma et al., 2006) , CeA tissues from saline-and morphine-treated rats were homogenized on ice for 10 min in the lysis buffer containing 50 mM Tris-Cl, 150 mM NaCl, 0.02 mM NaN2, 100 µg/ml phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, and 1% Triton X-100. The lysates were centrifuged at 14,000 rpm for 10 min at 4°C, and the supernatant was used for SDS-PAGE. Protein concentrations were determined by using the Bio-Rad (Hercules, CA) protein assay kit.
Western blotting. The samples were treated with SDS sample buffer at 95°C for 5 min, loaded on a 10% SDS-polyacrylamide gel and blotted to a nitrocellulose membrane.
The blots were incubated overnight at 4°C with a goat polycolnal anti-DOR primary 
Results
Morphine conditioning induces reward behavior through opioid receptors.
To demonstrate a rat model of opioid reward, we conditioned rats with repeated morphine, a strong rewarding opioid, or saline and performed a behavioral test of conditioned place preference (CPP), a commonly used behavioral measure for the rewarding effect of opioids and other abused drugs in animals (Tzschentke, 2007) . Morphine conditioning induced consistent CPP behavior in all conditioned rats (n=15, Fig. 1 ), consistent with a brief report in our previous study of alcohol reward (Zhu et al., 2007) . One day after the postconditioning test, we conducted another CPP test on the same animal without additional morphine administration and found that the CPP behavior persisted without apparent decline in magnitude after administration of saline. However, when naloxone (1.5 mg/kg, i.p.), a non-selective opioid receptor antagonist, was instead administered prior to the test, the CPP behavior was completely reversed, suggesting that the reward behavior of morphine generally requires activation of opioid receptors (Fig. 1) .
Morphine enhances glutamate synaptic transmission. We then prepared CeA slices from those rats treated with morphine and displaying resultant CPP behavior to investigate morphine-induced adaptive changes in glutamate synaptic activity in CeA neurons under whole-cell voltage-clamp conditions in vitro. To assess a potential change in general synaptic strength of CeA glutamate synapses, we compared input-output responses of evoked synaptic currents from those morphine-treated rats vs. saline-treated control rats. To further evaluate changes in the glutamate synaptic properties of CeA neurons, we used the paradigm of paired-pulse ratio (PPR), a commonly used synaptic assessment for changes in presynaptic transmitter release and a synaptic property that is less variable among cells in a slice preparation, allowing feasible comparison between two different groups of cells (Bie et al., 2005) . In control slices, a pair of stimuli at three different intervals all evoked a PPR of >1, indicating a consistent synaptic facilitation under these conditions (Fig. 3) . In neurons from morphine-treated rats, the same simulation also evoked consistent synaptic facilitation, but the value of PPRs was significantly reduced at all three stimulus intervals. This suggests a stimulus interval-independent reduction in the PPR of glutamate EPSCs. Given the well-documented inverse relationship between PPR and presynaptic release of neurotransmitters (Dobrunz and Stevens, 1997; Bie et al., 2005; Zhu et al., 2007) , the reduced PPR indicates that synaptic release of glutamate in CeA neurons is functionally increased by morphine, contributing to the strengthened neurotransmission of glutamate synapses in the CeA of morphine-treated rats.
Morphine recruits functional delta-opioid receptors. Whereas MOR plays an essential role in opioid reward and addiction, the function of DOR remains largely unclear (Contet et al., 2004) . To determine whether DOR had a role in this morphine rewardrelated synaptic adaptation, we examined DOR actions on glutamate synaptic activity in CeA neurons from morphine-treated rats as well as control rats. In CeA slices from control This Fig. 4A , B), consistent with our previous report showing a lack of functional DOR on glutamate synapses in CeA neurons from normal rats (Zhu and Pan, 2005) . In contrast, in CeA slices from morphine-treated rats, we found that DPDPE (1 μM) significantly inhibited the EPSC amplitude in 12 out of 17 cells generally surveyed (control, 258 + 37 pA, DPDPE, 185 + 32 pA, , n=12, p<0.01, Fig. 4A (Fig. 4C ). This finding indicates that repeated morphine treatment that causes the reward-related CPP behavior recruits new functional DOR on the majority of glutamate synapses in a brain area importantly involved in opioid reward and drug addiction.
DOR inhibition of EPSCs is presynaptic. We next determined whether the EPSC
inhibition by the newly emerged DOR involved a presynaptic site, a postsynaptic site or both, using synaptic analyses of both PPR and miniature EPSCs. Consistent with a lack of functional DOR on CeA glutamate synapses under normal conditions, DPDPE (1 μM)
failed to alter the PPR of EPSCs in CeA slices from control rats (control, 1.62 + 0.14, DPDPE, 1.58 + 0.11, n=6, p>0.05, Fig. 5 ). In CeA slices from morphine-treated rats, This article has not been copyedited and formatted. The final version may differ from this version. Morphine increases DOR proteins in CeA synaptosomes. Finally, we explored the potential mechanism for the DOR emergence on CeA glutamatergic terminals. Given the previous evidence for morphine-induced exocytotic membrane trafficking of intracellular DOR in pain-modulating neurons (Morinville et al., 2004; Ma et al., 2006; Zhang et al., 2006) , we proposed that a similar mechanism of DOR membrane trafficking could account for the DOR appearance on glutamate terminals in CeA neurons. To demonstrate a potential increase in the functional expression of DOR proteins on surface membrane of synaptic terminals, we used CeA preparations of synaptosomes, which are thought to be largely free of cell body contents and have a greatly reduced amount of intraterminal contents (Ghijsen et al., 2003; Dunkley et al., 2008) , including presumably intraThis article has not been copyedited and formatted. The final version may differ from this version. CeA tissues taken from the morphine-treated rats (n=6) remained unchanged in our Western blot analysis (Fig. 7A, C) , consistent with our previous report on brainstem neurons (Ma et al., 2006) . However, in CeA synaptosomal preparations of synaptic terminals as identified by the specific synaptic terminal marker synaptophysin, the amount of DOR protein was significantly increased by the morphine treatment (Fig. 7B , C, n= 6 rats in both control and morphine groups). This result indicates that repeated morphine likely increases the expression of DOR proteins on terminal membrane without significant new synthesis of DOR proteins in the CeA.
Discussion
In this study, we have shown that repeated morphine-conditioning treatment, which induces the CPP behavior related to morphine reward, enhances glutamate synaptic strength and recruits new functional DOR on glutamate synapses in neurons of the CeA, an important forebrain structure implicated in the rewarding effect of and addiction to many abused drugs including opioids. It appears that the DOR emerges on terminal membrane of presynaptic glutamatergic synapses onto CeA neurons and its activation inhibits glutamate synaptic activity, which has been enhanced by the morphine treatment.
Mechanisms for DOR induction.
Increasing evidence has emerged from a number of recent studies showing that under normal conditions, DOR is predominantly localized in intracellular compartments, such as cytoplasmic large dense-core vesicles and Golgi/endoplasmic reticulum-associated structures, in many types of central neurons in the brain and spinal cord Cahill et al., 2007) . Intracellular localization of non-functional DOR is consistent with recent reports that DOR agonists lack a significant effect on brainstem and midbrain neurons under control conditions (Hack et al., 2005; Ma et al., 2006) , and with our observation in this study of the lack of a DOR agonist effect in control CeA neurons, although a DOR-mediated hyperpolarization was reported in a small population of normal brainstem neurons after acute application of MOR agonists (Marinelli et al., 2005) . Interestingly, chronic, but not acute, morphine has been shown to induce exocytotic membrane trafficking of intracellular DOR from cytoplasmic compartments to surface membrane with detailed anatomical and molecular evidence (Morinville et al., 2004; Guan et al., 2005; Hack et al., 2005; Ma et al., 2006) .
Much of our current knowledge on DOR anatomical localization and exocytotic
This article has not been copyedited and formatted. The final version may differ from this version. which allows translocation analysis with confocal microscopy (Morinville et al., 2004; Guan et al., 2005; Patwardhan et al., 2005) . Demonstrating DOR translocation in synaptic terminals is more challenging technically and our own confocal study in brainstem neurons has shown morphine-induced increase in DOR-immunoreactive varicosities apposing postsynaptic membrane (presumably synaptic contacts), consistent with the mechanism of DOR membrane trafficking (Ma et al., 2006) . In this study of CeA neurons, we show a morphine-induced selective increase in DOR proteins in CeA synaptosomes, of which the preparation procedures have removed most cell body contents and cytoplasmic contents of synaptic terminals, such as endoplasmic reticulum, small synaptic vesicles and likely, intraterminal DOR contained in large dense-core vesicles, while keeping terminal membranebound proteins such as receptors and ion channels intact (Gottfried et al., 2003; Dunkley et al., 2008) . This observation of increased DOR expression on terminal membrane, but not total DOR proteins in CeA neurons, further supports the notion that a similar mechanism of DOR membrane trafficking also occurs in central synaptic terminals and accounts for the morphine-induced recruitment of new functional DOR for synaptic modulation. The molecular determinants and signaling pathways that mediate chronic morphine-induced DOR membrane trafficking in central neurons are still unknown at present.
DOR inhibition of glutamate neurotransmission.
For presynaptic DOR, a previous study and our previous report have identified the induction of new functional DOR on GABAergic terminals in midbrain and brainstem neurons after exposure to chronic morphine (Hack et al., 2005; Ma et al., 2006) . Noticeably, all these observations of morphine induction of both pre-and postsynaptic DOR were made in central and peripheral of enhanced analgesic effects of DOR through its increased surface expression (Ma et al., 2006; Zhang et al., 2006; Cahill et al., 2007; Sykes et al., 2007) . The current study provides evidence for the occurrence of this adaptive DOR function on central glutamate terminals in the CeA, suggesting that chronic exposure to opioids may have much broader influence on synaptic plasticity and opioid receptor functions across many brain functions, and particularly, extending the DOR adaptation to a brain area increasingly implicated in opioid reward and drug addiction. Given the critical roles of central glutamate synaptic activity and CeA functions in the brain's adaptive responses to opioids and other abused drugs in drug addiction (Baxter and Murray, 2002; See et al., 2003; Siggins et al., 2003) , the present findings may stimulate new mechanistic pursuits in future studies on DOR functions in opioid reward and drug addiction in the context of prolonged exposure to MOR agonists. 
Functional considerations.
We have shown recently that alcohol and morphineinduced enhancement of glutamate synaptic activity in CeA neurons is required to maintain the CPP behavior (Zhu et al., 2007) . Our present findings demonstrate that it also requires a general activation of opioid receptors, and suggest a likely role of the emerged DOR in this behavior of opioid reward through modulation of CeA glutamate synaptic transmission. injection of saline (n=7 rats) or naloxone (1.5 mg/kg, n=8 rats). ** p<0.01. EPSCs. The estimated EC 50 for the DPDPE effect is 50.7 nM (n=6-11 for each data point).
** p<0.01. 
